![Interleukin-6 serum level and -597 A/G gene polymorphism in moderate and severe chronic obstructive pulmonary disease - Ana Florica Chiș, Andreea Cătană, Olga Sorițău, Bogdan Augustin Chiș, Ancuța Cutaș, Carmen Monica Pop, Interleukin-6 serum level and -597 A/G gene polymorphism in moderate and severe chronic obstructive pulmonary disease - Ana Florica Chiș, Andreea Cătană, Olga Sorițău, Bogdan Augustin Chiș, Ancuța Cutaș, Carmen Monica Pop,](https://journals.sagepub.com/cms/10.1177/2058739220966469/asset/images/large/10.1177_2058739220966469-fig2.jpeg)
Interleukin-6 serum level and -597 A/G gene polymorphism in moderate and severe chronic obstructive pulmonary disease - Ana Florica Chiș, Andreea Cătană, Olga Sorițău, Bogdan Augustin Chiș, Ancuța Cutaș, Carmen Monica Pop,
![IJMS | Free Full-Text | Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients IJMS | Free Full-Text | Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients](https://www.mdpi.com/ijms/ijms-17-01861/article_deploy/html/images/ijms-17-01861-g001.png)
IJMS | Free Full-Text | Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
![Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis | The Journal of Rheumatology Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/40/7/1074/F1.large.jpg)
Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis | The Journal of Rheumatology
![Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models](https://www.spandidos-publications.com/article_images/mmr/7/5/MMR-07-05-1470-g00.jpg)
Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models
![Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/462f0f6f-a326-4055-8ad3-8cb256c67314/gr1_lrg.jpg)
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
![High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis - ScienceDirect High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572821001612-ga1.jpg)
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis - ScienceDirect
![Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha | Annals of Hepatology Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//16652681/0000000200000002/v1_201906300836/S1665268119321477/v1_201906300836/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeKOJqKH5+Za6P+RA5Vq9Dl12PaTTgl2nVmvRMd29vkiwodSdgyThLirKEKIeFDIY8OvyfMw19FHF8/u8aSHgJVo0zw/JgScExzis0JsnhyauKKrkmFkO7SrgmA/jgsWctdzycQWQwjaoLKkiFMQ4uwAUaUaYNsZV9npArFbGMWNI2Tlc4Q3dAPedAfurCkUBKWtdF5quA3/hjki9/m6YuBE/qpmwkNEcOypuMaAui+SEcL3urxQ8JVi/X9zb0iIoA=)
Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha | Annals of Hepatology
![Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways | Scientific Reports Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep23010/MediaObjects/41598_2016_Article_BFsrep23010_Fig1_HTML.jpg)
Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways | Scientific Reports
Electrochemical Immunosensing of Interleukin-6 in Human Cerebrospinal Fluid and Human Serum as an Early Biomarker for Traumatic Brain Injury | ACS Measurement Science Au
![Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia](https://www.frontiersin.org/files/Articles/613422/fimmu-12-613422-HTML-r2/image_m/fimmu-12-613422-g001.jpg)
Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
![Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis | Arthritis Research & Therapy | Full Text Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Far4672/MediaObjects/13075_2013_Article_4244_Fig1_HTML.jpg)
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis | Arthritis Research & Therapy | Full Text
![Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition | Journal for ImmunoTherapy of Cancer Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/1/e000842/F5.large.jpg)
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition | Journal for ImmunoTherapy of Cancer
![Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02571-x/MediaObjects/12967_2020_2571_Fig1_HTML.png)
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text
Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus | PLOS Neglected Tropical Diseases
![Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02571-x/MediaObjects/12967_2020_2571_Fig2_HTML.png)
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study | Journal of Translational Medicine | Full Text
![Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome | European Respiratory Society Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome | European Respiratory Society](https://erj.ersjournals.com/content/erj/early/2020/08/28/13993003.03006-2020/F2.large.jpg)